2021-04-08 10:23:56 ORBC Taken private
04/08/21 04/0810:23 04/08/2110:23 | Orbcomm downgraded to Hold from Buy at Craig-HallumCraig-Hallum analyst Anthony Stoss downgraded Orbcomm to Hold from Buy with a $11.50 price target after the company announced an agreement to be acquired by GI Partners for $11.50 per share in cash. |
|
---|
Recommendations
|
Paramount price target lowered to $44 from $47 at Citi »
06:26 05/23/22 05/2306:26 05/23/2206:26
PARA
Paramount
Citi analyst Jason… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Horizon Therapeutics initiated with a Market Perform at SVB Leerink »
06:26 05/23/22 05/2306:26 05/23/2206:26
HZNP
Horizon Therapeutics
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Consolidated Edison upgraded to Neutral from Sell at Guggenheim »
06:26 05/23/22 05/2306:26 05/23/2206:26
ED
Consolidated Edison
Guggenheim analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Dell Technologies price target lowered to $65 from $70 at Citi »
06:25 05/23/22 05/2306:25 05/23/2206:25
DELL
Dell Technologies
Citi analyst Jim Suva… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Marvell price target lowered to $80 from $95 at UBS »
06:24 05/23/22 05/2306:24 05/23/2206:24
MRVL
Marvell
UBS analyst Timothy… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Foot Locker price target raised to $32 from $30 »
06:24 05/23/22 05/2306:24 05/23/2206:24
FL
Foot Locker
Baird analyst Jonathan… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
AbbVie initiated with an Underperform at SVB Leerink »
06:23 05/23/22 05/2306:23 05/23/2206:23
ABBV
AbbVie
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright »
06:22 05/23/22 05/2306:22 05/23/2206:22
MITO
Stealth Biotherapeutics
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Zymeworks price target lowered to $40 from $44 at H.C. Wainwright »
06:21 05/23/22 05/2306:21 05/23/2206:21
ZYME
Zymeworks
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Atara Biotherapeutics price target lowered to $29 from $31 at H.C. Wainwright »
06:20 05/23/22 05/2306:20 05/23/2206:20
ATRA
Atara Biotherapeutics
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Snowflake price target lowered to $180 from $260 at UBS »
06:20 05/23/22 05/2306:20 05/23/2206:20
SNOW
Snowflake
UBS analyst Karl… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Amgen initiated with a Market Perform at SVB Leerink »
06:20 05/23/22 05/2306:20 05/23/2206:20
AMGN
Amgen
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Angion Biomedica price target lowered to $28 from $32 at H.C. Wainwright »
06:20 05/23/22 05/2306:20 05/23/2206:20
ANGN
Angion Biomedica
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Spero Therapeutics price target lowered to $10 from $37 at H.C. Wainwright »
06:20 05/23/22 05/2306:20 05/23/2206:20
SPRO
Spero Therapeutics
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
BioXcel Therapeutics price target lowered to $110 from $134 at H.C. Wainwright »
06:19 05/23/22 05/2306:19 05/23/2206:19
BTAI
BioXcel Therapeutics
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Xencor price target lowered to $42 from $66 at Piper Sandler »
06:18 05/23/22 05/2306:18 05/23/2206:18
XNCR
Xencor
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Sutro Biopharma price target lowered to $14 from $29 at Piper Sandler »
06:18 05/23/22 05/2306:18 05/23/2206:18
STRO
Sutro Biopharma
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Omega Therapeutics price target lowered to $7 from $30 at Piper Sandler »
06:18 05/23/22 05/2306:18 05/23/2206:18
OMGA
Omega Therapeutics
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
NextCure price target lowered to $13 from $21 at Piper Sandler »
06:17 05/23/22 05/2306:17 05/23/2206:17
NXTC
NextCure
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
JPMorgan sees 12.5%-13% CET1 ratio at 1Q24 »
06:17 05/23/22 05/2306:17 05/23/2206:17
JPM
JPMorgan
The company's ROTCE… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Seres Therapeutics price target lowered to $7 from $32 at Piper Sandler »
06:17 05/23/22 05/2306:17 05/23/2206:17
MCRB
Seres Therapeutics
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Kymera Therapeutics price target lowered to $43 from $91 at Piper Sandler »
06:17 05/23/22 05/2306:17 05/23/2206:17
KYMR
Kymera Therapeutics
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Kronos Bio price target lowered to $13 from $30 at Piper Sandler »
06:17 05/23/22 05/2306:17 05/23/2206:17
KRON
Kronos Bio
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Jounce Therapeutics price target lowered to $9 from $17 at Piper Sandler »
06:17 05/23/22 05/2306:17 05/23/2206:17
JNCE
Jounce Therapeutics
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Infinity Pharmaceuticals price target lowered to $3 from $4 at Piper Sandler »
06:17 05/23/22 05/2306:17 05/23/2206:17
INFI
Infinity Pharmaceuticals
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|